{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:49:05Z","timestamp":1763747345894},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,11,5]],"date-time":"2014-11-05T00:00:00Z","timestamp":1415145600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Pharmacokinet"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1007\/s40262-014-0203-9","type":"journal-article","created":{"date-parts":[[2014,11,4]],"date-time":"2014-11-04T04:01:23Z","timestamp":1415073683000},"page":"385-395","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Population Pharmacokinetic Meta-Analysis to Bridge Ferumoxytol Plasma Pharmacokinetics Across Populations"],"prefix":"10.1007","volume":"54","author":[{"given":"Nele","family":"Plock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Facius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gezim","family":"Lahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nolan","family":"Wood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Frigo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Deveney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pau","family":"Aceves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,11,5]]},"reference":[{"key":"203_CR1","doi-asserted-by":"crossref","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, et al. Chronic kidney disease: global dimension and perspectives [published erratum appears in Lancet 2013;382(9888):208]. Lancet. 2013;382(9888):260\u201372.","DOI":"10.1016\/S0140-6736(13)60687-X"},{"issue":"3","key":"203_CR2","first-page":"198","volume":"42","author":"M Akmal","year":"1994","unstructured":"Akmal M, Sawelson S, Karubian F, Gadallah M. The prevalence and significance of occult blood loss in patients with predialysis advanced chronic renal failure (CRF), or receiving dialytic therapy. Clin Nephrol. 1994;42(3):198\u2013202.","journal-title":"Clin Nephrol."},{"issue":"4","key":"203_CR3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1365-2141.1991.tb08093.x","volume":"79","author":"MP Kooistra","year":"1991","unstructured":"Kooistra MP, van Es A, Struyvenberg A, Marx JJ. Iron metabolism in patients with the anaemia of end-stage renal disease during treatment with recombinant human erythropoietin. Br J Haematol. 1991;79(4):634\u20139.","journal-title":"Br J Haematol."},{"issue":"Suppl 2","key":"203_CR4","first-page":"21","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F, Aljama P, B\u00e1r\u00e1ny P, Canaud B, Carrera F, Eckardt KU, H\u00f6rl WH, Macdougal IC, Macleod A, Wiecek A, Cameron S, European Best Practice Guidelines Working Group. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant. 2004;19(Suppl 2):21\u201347.","journal-title":"Nephrol Dial Transplant."},{"issue":"2","key":"203_CR5","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1177\/0884533608314536","volume":"23","author":"SF Clark","year":"2008","unstructured":"Clark SF. Iron deficiency anemia. Nutr Clin Pract. 2008;23(2):128\u201341.","journal-title":"Nutr Clin Pract."},{"key":"203_CR6","doi-asserted-by":"crossref","first-page":"846824","DOI":"10.1100\/2012\/846824","volume":"2012","author":"P Santiago","year":"2012","unstructured":"Santiago P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. Sci World J. 2012;2012:846824. doi: 10.1100\/2012\/846824 (Epub 2012 May 2).","journal-title":"Sci World J."},{"key":"203_CR7","doi-asserted-by":"crossref","first-page":"f4822","DOI":"10.1136\/bmj.f4822","volume":"347","author":"E Litton","year":"2013","unstructured":"Litton E, Xiao J, Ho KM. Safety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trials. BMJ. 2013;347:f4822.","journal-title":"BMJ."},{"issue":"15","key":"203_CR8","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.2165\/11209880-000000000-00000","volume":"72","author":"PL McCormack","year":"2012","unstructured":"McCormack PL. Ferumoxytol: in iron deficiency anaemia in adults with chronic kidney disease. Drugs. 2012;72(15):2013\u201322.","journal-title":"Drugs."},{"issue":"2","key":"203_CR9","doi-asserted-by":"crossref","first-page":"386","DOI":"10.2215\/CJN.02840608","volume":"4","author":"R Provenzano","year":"2009","unstructured":"Provenzano R, Schiller B, Rao M, Coyne D, Brenner L, Pereira BJ. Ferumoxytol as an intravenous iron replacement therapy in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(2):386\u201393.","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"203_CR10","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1111\/j.1523-1755.2005.00598.x","volume":"68","author":"BS Spinowitz","year":"2005","unstructured":"Spinowitz BS, Schwenk MH, Jacobs PM, Bolton WK, Kaplan MR, Charytan C, Galler M. The safety and efficacy of ferumoxytol therapy in anemic chronic kidney disease patients. Kidney Int. 2005;68(4):1801\u20137.","journal-title":"Kidney Int."},{"issue":"5","key":"203_CR11","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1053\/j.ajkd.2008.08.001","volume":"52","author":"A Singh","year":"2008","unstructured":"Singh A, Patel T, Hertel J, Bernardo M, Kausz A, Brenner L. Safety of ferumoxytol in patients with anemia and CKD. Am J Kidney Dis. 2008;52(5):907\u201315.","journal-title":"Am J Kidney Dis."},{"issue":"2","key":"203_CR12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/clpt.2010.80","volume":"88","author":"AB Pai","year":"2010","unstructured":"Pai AB, Nielsen JC, Kausz A, Miller P, Owen JS. Plasma pharmacokinetics of two consecutive doses of ferumoxytol in healthy subjects. Clin Pharmacol Ther. 2010;88(2):237\u201342.","journal-title":"Clin Pharmacol Ther."},{"issue":"1","key":"203_CR13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1046\/j.1523-1755.2002.00099.x","volume":"61","author":"JK Leypoldt","year":"2002","unstructured":"Leypoldt JK, Cheung AK, Delmez JA, Gassman JJ, Levin NW, Lewis JA, Lewis JL, Rocco MV. Relationship between volume status and blood pressure during chronic hemodialysis. Kidney Int. 2002;61(1):266\u201375.","journal-title":"Kidney Int."},{"issue":"9","key":"203_CR14","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1097\/01.ASN.0000082998.50730.FA","volume":"14","author":"S Mitra","year":"2003","unstructured":"Mitra S, Chamney P, Greenwood R, Farrington K. Serial determinations of absolute plasma volume with indocyanine green during hemodialysis. J Am Soc Nephrol. 2003;14(9):2345\u201351.","journal-title":"J Am Soc Nephrol."},{"key":"203_CR15","unstructured":"The International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH). Available from: http:\/\/www.ich.org ."},{"issue":"4","key":"203_CR16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1159\/000087212","volume":"25","author":"R Landry","year":"2005","unstructured":"Landry R, Jacobs PM, Davis R, Shenouda M, Bolton WK. Pharmacokinetic study of ferumoxytol: a new iron replacement therapy in normal subjects and hemodialysis patients. Am J Nephrol. 2005;25(4):400\u201310.","journal-title":"Am J Nephrol."},{"key":"203_CR17","unstructured":"Beal SL, Boeckmann AJ, Sheiner LB. NONMEM users guide. Parts I\u2013VIII. ICON Development Solutions."},{"key":"203_CR18","unstructured":"Holford N. The visual predictive check\u2014superiority to standard diagnostic (Rorschach) Plots. 2005. Available from: http:\/\/www.page-meeting.org\/?abstract=738 . Accessed 7\u00a0Apr 2014."},{"key":"203_CR19","unstructured":"Feraheme: dosage and administration. Full prescribing information. Available from: http:\/\/www.feraheme.com\/ . Accessed 7 Apr 2014."},{"issue":"Suppl 8","key":"203_CR20","first-page":"20","volume":"11","author":"KS Katzarski","year":"1996","unstructured":"Katzarski KS. Monitoring of blood volume during haemodialysis treatment of acute renal and multiple organ failures. Nephrol Dial Transplant. 1996;11(Suppl 8):20\u20133.","journal-title":"Nephrol Dial Transplant."},{"issue":"3","key":"203_CR21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1208\/s12248-009-9133-0","volume":"11","author":"RM Savic","year":"2009","unstructured":"Savic RM, Karlsson MO. Importance of shrinkage in empirical bayes estimates for diagnostics: problems and solutions. AAPS J. 2009;11(3):558\u201369.","journal-title":"AAPS J."},{"key":"203_CR22","unstructured":"Holford N, Kirkpatrick C, Duffull S. NONMEM termination status is not an important indicator of the quality of bootstrap parameter estimates. 2006. Available from: http:\/\/www.page-meeting.org\/?abstract=992 . Accessed 14 Apr 2014."},{"issue":"2","key":"203_CR23","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/019262339502300203","volume":"23","author":"LZ Benet","year":"1995","unstructured":"Benet LZ, Zia-Amirhosseini P. Basic principles of pharmacokinetics. Toxicol Pathol. 1995;23(2):115\u201323.","journal-title":"Toxicol Pathol."},{"key":"203_CR24","unstructured":"Rienso. Summary of product characteristics. Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002215\/WC500129749.pdf . Accessed 14 Apr 2014."},{"key":"203_CR25","first-page":"991","volume-title":"Irwin and Rippe\u2019s intensive care medicine","author":"RS Irwin","year":"2003","unstructured":"Irwin RS, Rippe JM. Irwin and Rippe\u2019s intensive care medicine. 5th ed. USA: Lippincott Williams & Wilkins; 2003. p. 991.","edition":"5"},{"issue":"9 Suppl 10","key":"203_CR26","first-page":"25","volume":"16","author":"JL Spivak","year":"2002","unstructured":"Spivak JL. Iron and the anemia of chronic disease. Oncology (Williston Park). 2002;16(9 Suppl 10):25\u201333.","journal-title":"Oncology (Williston Park)"}],"container-title":["Clinical Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40262-014-0203-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-014-0203-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40262-014-0203-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T13:12:20Z","timestamp":1551186740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40262-014-0203-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,5]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["203"],"URL":"https:\/\/doi.org\/10.1007\/s40262-014-0203-9","relation":{},"ISSN":["0312-5963","1179-1926"],"issn-type":[{"value":"0312-5963","type":"print"},{"value":"1179-1926","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,5]]}}}